Go Back

Company or ticker...

NeoGenomics

NeoGenomics provides cancer-focused genetic testing and oncology diagnostic services.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

NEO

2.2B

2.9

n/a

44.11%

Key Facts

M. Cap

PS

PE

YTD

2.2B

2.9

n/a

44.11%

10MA

20MA

50MA

200MA

$NEO

The Fullstack Investor

by Lin

v1.3

Join Now

Join Now

The Fullstack Investor

by Lin

v1.3

Join Now

Join Now

Join Now

Join Now